Reflectometric Measurement of Retinal Oxygen Saturation in Patients With Chronic Obstructive Pulmonary Disease (COPD) Grade IV and Healthy Subjects

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-11-30

Study Completion Date

2012-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An adequate oxygenation and retinal perfusion is essential for the function of the inner retina. There is a wide range of autoregulation mechanisms to ensure a sufficient ocular blood and oxygen supply during changes in systemic blood pressure or intraocular pressure (IOP). Nonetheless, various retinopathies such as diabetic retinopathy, which is the leading cause of blindness in people aged 20-65 in the western world, are highly associated with hypoxia (Pemp and Schmetterer 2008). Hence, measurements of oxygen levels in retinal vessels are needed to further our understanding of these ischemic diseases. It is a well known fact and a commonly employed method to measure oxygen saturation of blood through light transmission (Kramer 1934). However, this approach is not feasible in the human eye. Therefore, reflection must be used, meaning the amount of incident light must be estimated based on the amount of light reflected (for a review see Harris 2003). This is a difficult task and investigators in this field have encountered several problems, including optical complexities, nonlinear sensors and eye movement (Beach et al 1999; Delori 1988). Nonetheless considerable progress has been made over the past decades and the development of an reliable oximeter reported (Hardarson et al 2006).

In the present study this technique will be applied in healthy subjects as well as in patients with COPD during room-air conditions. The procedure takes approximately 15 minutes in each subject and will be performed in only one eye.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Short Term and Day to Day Reproducibility of Reflectometric Measurement of Retinal Oxygen Saturation in Healthy Subjects

NCT00991900

Ocular Physiology

WITHDRAWN

Measurement of Retinal Blood Flow, Retinal Oxygenation and Retinal Oxygen Extraction in Healthy Subjects During Normoxia and Systemic Hyperoxia

NCT00914407

Healthy Normoxia Systemic Hypoxia

COMPLETED NA

Age-related Changes in Retinal Oxygen Extraction in Healthy Subjects

NCT06643403

Healthy Participants Retinal Oxygen Extraction

RECRUITING NA

Study of Retinal Oxygenation in Central Retinal Vein Occlusion

NCT02523339

Retinal Vein Occlusion

COMPLETED

Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19

NCT05650905

COVID-19 Post-COVID-19 Syndrome

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinal Artery Retinal Veins

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy subjects

20 healthy subjects will be included

No interventions assigned to this group

COPD Patients

20 Patients with Grade IV COPD will be included

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women aged between 18 and 99 years
* Tiffeneau Index \> 70 %
* Body mass index between 15th and 85th percentile
* Normal ophthalmic findings, ametropia \< 3 Dpt.

* Men and women aged between 18 and 99 years
* COPD grade IV, oxygen dependent and with a forced expiratory volume in 1 second (FEV1) \< 30 %
* Body mass index between 15th and 85th percentile
* Normal ophthalmic findings, ametropia \< 3 Dpt.

Exclusion Criteria

Healthy subjects:

* Regular use of medication, abuse of alcoholic beverages, participation in a clinical trial in the 3 weeks preceding the study
* Treatment in the previous 3 weeks with any drug except oral contraceptives
* Symptoms of a clinically relevant illness in the 3 weeks before the study day
* Blood donation during the previous 3 weeks

COPD patients:

* Abuse of alcoholic beverages, participation in a clinical trial in the 3 weeks preceding the study
* Health status which does interfere with study procedure or their safety
* Blood donation during the previous 3 weeks
* Symptoms of a clinically relevant illness other than COPD or COPD related in the 3 weeks before the study day

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes